[Total pelvic exenteration].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 2010 Vol.81(10) p. 897-901

Heger U, Koch M, Büchler MW, Weitz J

Abstract

Over the last decades total pelvic exenteration (TPE) has evolved into an established and safe surgical technique for locally advanced pelvic malignancies. Depending on the type of cancer 5 year overall survival rates of up to 66% and a satisfactory postsurgical quality of life have been reported. Currently infiltration of the pelvic side wall and resectable metastases are not necessarily a contraindication to a curative approach; furthermore, TPE can also be useful in palliative surgery. In locally recurrent rectal cancer TPE is the treatment of choice if the tumor is deemed resectable. A multidisciplinary diagnostic and therapeutic approach is of utmost importance, hence patients should be treated in specialized centers.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 pelvic scispacy 1
약물 TPE → total pelvic exenteration scispacy 1
질환 TPE → total pelvic exenteration scispacy 1
질환 pelvic malignancies scispacy 1
질환 cancer C0006826
Malignant Neoplasms
scispacy 1
질환 tumor C0027651
Neoplasms
scispacy 1
질환 rectal cancer TPE scispacy 1
기타 wall scispacy 1
기타 patients scispacy 1

MeSH Terms

Female; Humans; Neoplasm Recurrence, Local; Palliative Care; Pelvic Exenteration; Postoperative Complications; Plastic Surgery Procedures; Rectal Neoplasms; Surgery, Plastic; Survival Rate; Ureter; Uterine Cervical Neoplasms